{"id":27089,"date":"2020-07-08T07:57:37","date_gmt":"2020-07-08T07:57:37","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=27089"},"modified":"2021-10-08T05:53:13","modified_gmt":"2021-10-08T05:53:13","slug":"entacapone","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/entacapone\/","title":{"rendered":"Entacapone"},"content":{"rendered":"<p>An inhibitor of catechol-o-methyltransferase (COMT) used as an adjunct to carbidopa-levodopa therapy in the treatment of parkinson\u2019s disease for patients who experience the signs and symptoms of end-of-dose \u201cwearing-off.\u201d Entacapone primarily inhibits the peripheral metabolism of levodopa by COMT, allowing greater and more sustained levels of levodopa to penetrate the brain, where it can be converted to dopamine. Marketed under the brand name comtan.<\/p>\n<hr \/>\n<p>A drug used to treat Parkinson disease. Entacapone (Comtan) is used along with Levodopa and carbidopa to treat Parkinson disease because it increases levels of levodopa in the blood, which helps more of the drug get into the brain.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>An inhibitor of catechol-o-methyltransferase (COMT) used as an adjunct to carbidopa-levodopa therapy in the treatment of parkinson\u2019s disease for patients who experience the signs and symptoms of end-of-dose \u201cwearing-off.\u201d Entacapone primarily inhibits the peripheral metabolism of levodopa by COMT, allowing greater and more sustained levels of levodopa to penetrate the brain, where it can be [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-27089","post","type-post","status-publish","format-standard","hentry","category-e"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Entacapone - Definition of Entacapone<\/title>\n<meta name=\"description\" content=\"An inhibitor of catechol-o-methyltransferase (COMT) used as an adjunct to carbidopa-levodopa therapy in the treatment of parkinson\u2019s disease for patients who experience the signs and symptoms of end-of-dose \u201cwearing-off.\u201d Entacapone primarily inhibits the peripheral metabolism of levodopa by COMT, allowing greater and more sustained levels of levodopa to penetrate the brain, where it can be converted to dopamine. Marketed under the brand name comtan.A drug used to treat Parkinson disease. Entacapone (Comtan) is used along with Levodopa and carbidopa to treat Parkinson disease because it increases levels of levodopa in the blood, which helps more of the drug get into the brain.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/entacapone\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Entacapone - Definition of Entacapone\" \/>\n<meta property=\"og:description\" content=\"An inhibitor of catechol-o-methyltransferase (COMT) used as an adjunct to carbidopa-levodopa therapy in the treatment of parkinson\u2019s disease for patients who experience the signs and symptoms of end-of-dose \u201cwearing-off.\u201d Entacapone primarily inhibits the peripheral metabolism of levodopa by COMT, allowing greater and more sustained levels of levodopa to penetrate the brain, where it can be converted to dopamine. Marketed under the brand name comtan.A drug used to treat Parkinson disease. Entacapone (Comtan) is used along with Levodopa and carbidopa to treat Parkinson disease because it increases levels of levodopa in the blood, which helps more of the drug get into the brain.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/entacapone\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-08T07:57:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-10-08T05:53:13+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/entacapone\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/entacapone\/\",\"name\":\"Entacapone - Definition of Entacapone\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2020-07-08T07:57:37+00:00\",\"dateModified\":\"2021-10-08T05:53:13+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"An inhibitor of catechol-o-methyltransferase (COMT) used as an adjunct to carbidopa-levodopa therapy in the treatment of parkinson\u2019s disease for patients who experience the signs and symptoms of end-of-dose \u201cwearing-off.\u201d Entacapone primarily inhibits the peripheral metabolism of levodopa by COMT, allowing greater and more sustained levels of levodopa to penetrate the brain, where it can be converted to dopamine. Marketed under the brand name comtan.A drug used to treat Parkinson disease. Entacapone (Comtan) is used along with Levodopa and carbidopa to treat Parkinson disease because it increases levels of levodopa in the blood, which helps more of the drug get into the brain.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/entacapone\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/entacapone\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/entacapone\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Entacapone\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Entacapone - Definition of Entacapone","description":"An inhibitor of catechol-o-methyltransferase (COMT) used as an adjunct to carbidopa-levodopa therapy in the treatment of parkinson\u2019s disease for patients who experience the signs and symptoms of end-of-dose \u201cwearing-off.\u201d Entacapone primarily inhibits the peripheral metabolism of levodopa by COMT, allowing greater and more sustained levels of levodopa to penetrate the brain, where it can be converted to dopamine. Marketed under the brand name comtan.A drug used to treat Parkinson disease. Entacapone (Comtan) is used along with Levodopa and carbidopa to treat Parkinson disease because it increases levels of levodopa in the blood, which helps more of the drug get into the brain.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/entacapone\/","og_locale":"en_US","og_type":"article","og_title":"Entacapone - Definition of Entacapone","og_description":"An inhibitor of catechol-o-methyltransferase (COMT) used as an adjunct to carbidopa-levodopa therapy in the treatment of parkinson\u2019s disease for patients who experience the signs and symptoms of end-of-dose \u201cwearing-off.\u201d Entacapone primarily inhibits the peripheral metabolism of levodopa by COMT, allowing greater and more sustained levels of levodopa to penetrate the brain, where it can be converted to dopamine. Marketed under the brand name comtan.A drug used to treat Parkinson disease. Entacapone (Comtan) is used along with Levodopa and carbidopa to treat Parkinson disease because it increases levels of levodopa in the blood, which helps more of the drug get into the brain.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/entacapone\/","og_site_name":"Glossary","article_published_time":"2020-07-08T07:57:37+00:00","article_modified_time":"2021-10-08T05:53:13+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/entacapone\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/entacapone\/","name":"Entacapone - Definition of Entacapone","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2020-07-08T07:57:37+00:00","dateModified":"2021-10-08T05:53:13+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"An inhibitor of catechol-o-methyltransferase (COMT) used as an adjunct to carbidopa-levodopa therapy in the treatment of parkinson\u2019s disease for patients who experience the signs and symptoms of end-of-dose \u201cwearing-off.\u201d Entacapone primarily inhibits the peripheral metabolism of levodopa by COMT, allowing greater and more sustained levels of levodopa to penetrate the brain, where it can be converted to dopamine. Marketed under the brand name comtan.A drug used to treat Parkinson disease. Entacapone (Comtan) is used along with Levodopa and carbidopa to treat Parkinson disease because it increases levels of levodopa in the blood, which helps more of the drug get into the brain.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/entacapone\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/entacapone\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/entacapone\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Entacapone"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/27089","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=27089"}],"version-history":[{"count":3,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/27089\/revisions"}],"predecessor-version":[{"id":132342,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/27089\/revisions\/132342"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=27089"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=27089"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=27089"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}